PCI centre (N=917) | Non-PCI centre (N=107) | p Value | |
---|---|---|---|
Age, years | 55.93±10.07 | 55.29±10.31 | 0.535 |
Male gender, N (%) | 788 (86) | 91 (85) | 0.80 |
Onset of STEMI, hours | 7 (0.25–240) | 3 (0.50–120) | 0.004 |
Systolic blood pressure, mm Hg | 129 (53–254) | 130 (60–200) | 0.456 |
Diastolic blood pressure, mm Hg | 78 (30–182) | 80 (0–120) | 0.255 |
Heart rate, bpm | 81 (20–210) | 86 (41–189) | 0.483 |
Source of referral, N (%) | |||
Public health centre | 6 (0.6) | 6 (5.6) | <0.001 |
Interhospital | 514 (56) | 10 (9.3) | <0.001 |
Intrahospital | 17 (1.85) | 2 (1.9) | 1.0 |
Self-walk-in | 367 (40) | 86 (80) | <0.001 |
Private clinic | 13 (1.41) | 3 (2.8) | 0.23 |
CAD risk factors, N (%) | |||
Hypertension | 496 (54) | 57 (53) | 0.951 |
Diabetes mellitus | 260 (28) | 28 (26) | 0.674 |
Family history | 138 (15) | 18 (17) | 0.600 |
Dyslipidaemia | 278 (30) | 25 (23) | 0.151 |
Smoker | 575 (63) | 53 (49) | 0.037 |
Location of MI, N (%) | |||
Anterior | 238 (26) | 37 (34.6) | 0.01 |
Killip class 1 at presentation, N (%) | 646 (70.4) | 89 (83.2) | 0.006 |
TIMI score ≥4, N (%) | 549 (59.8) | 25 (23.3) | <0.001 |
Acute reperfusion therapy, N (%) | |||
Fibrinolytic therapy | 59 (6.4) | 19 (17.7) | <0.001 |
Primary PCI | 473 (51.6) | NA | NA |
Non-reperfused | 385 (42) | 88 (82.2) | <0.001 |
CAD, coronary artery disease; MI, myocardial infarction; NA, not applicable; PCI, percutaneous coronary intervention; STEMI, ST segment elevation myocardial infarction; TIMI, thrombolysis in myocardial infarction.